Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James S Scott

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Expert Opinion on Therapeutic Patents|November 12, 2021
Selective estrogen receptor degraders (SERDs) and covalent antagonists (SERCAs): a patent review (2015-present)James S Scott, Bernard Barlaam
Bioorganic & Medicinal Chemistry|April 16, 2018
Practical application of ligand efficiency metrics in lead optimisationJames S Scott, Michael J Waring
Expert Opinion on Therapeutic Patents|June 5, 2024
Selective estrogen receptor degraders (SERDs) and covalent antagonists (SERCAs): a patent review (July 2021-December 2023)James S Scott, Teresa C M Klinowska
Chemical Communications (Cambridge, England)|January 17, 2013
Palladium catalyzed cyclizations of oxime esters with 1,1-disubstituted alkenes: synthesis of α,α-disubstituted dihydropyrroles and studies towards an asymmetric protocolAdele Faulkner, James S Scott, John F Bower
RSC Medicinal Chemistry|November 18, 2024
Property-based optimisation of PROTACsJames S Scott, Iacovos N Michaelides, Markus Schade
Journal of the American Chemical Society|May 29, 2015
An Umpolung Approach to Alkene Carboamination: Palladium Catalyzed 1,2-Amino-Acylation, -Carboxylation, -Arylation, -Vinylation, and -AlkynylationAdele Faulkner, James S Scott, John F Bower
Expert Opinion on Therapeutic Patents|August 31, 2022
A patent review of MAT2a inhibitors (2018-2021)Stephen J Atkinson, Laura Evans, James S Scott
Journal of Medicinal Chemistry|December 4, 2013
Medicinal chemistry of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)James S Scott, Frederick W Goldberg, Andrew V Turnbull
ACS Medicinal Chemistry Letters|August 17, 2019
Lowering Lipophilicity by Adding Carbon: AzaSpiroHeptanes, a log<i>D</i> Lowering TwistSébastien L Degorce, Michael S Bodnarchuk, James S Scott
Organic & Biomolecular Chemistry|December 12, 2017
Pd-Catalyzed C-H aziridination of 3,3,5,5-tetrasubstituted piperazin-2-onesThomas A Alanine, Stephen Stokes, Craig A Roberts, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Expert Opinion on Therapeutic Patents|November 12, 2021
Selective estrogen receptor degraders (SERDs) and covalent antagonists (SERCAs): a patent review (2015-present)James S Scott, Bernard Barlaam
Bioorganic & Medicinal Chemistry|April 16, 2018
Practical application of ligand efficiency metrics in lead optimisationJames S Scott, Michael J Waring
Expert Opinion on Therapeutic Patents|June 5, 2024
Selective estrogen receptor degraders (SERDs) and covalent antagonists (SERCAs): a patent review (July 2021-December 2023)James S Scott, Teresa C M Klinowska
Chemical Communications (Cambridge, England)|January 17, 2013
Palladium catalyzed cyclizations of oxime esters with 1,1-disubstituted alkenes: synthesis of α,α-disubstituted dihydropyrroles and studies towards an asymmetric protocolAdele Faulkner, James S Scott, John F Bower
RSC Medicinal Chemistry|November 18, 2024
Property-based optimisation of PROTACsJames S Scott, Iacovos N Michaelides, Markus Schade
Journal of the American Chemical Society|May 29, 2015
An Umpolung Approach to Alkene Carboamination: Palladium Catalyzed 1,2-Amino-Acylation, -Carboxylation, -Arylation, -Vinylation, and -AlkynylationAdele Faulkner, James S Scott, John F Bower
Expert Opinion on Therapeutic Patents|August 31, 2022
A patent review of MAT2a inhibitors (2018-2021)Stephen J Atkinson, Laura Evans, James S Scott
Journal of Medicinal Chemistry|December 4, 2013
Medicinal chemistry of inhibitors of 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1)James S Scott, Frederick W Goldberg, Andrew V Turnbull
ACS Medicinal Chemistry Letters|August 17, 2019
Lowering Lipophilicity by Adding Carbon: AzaSpiroHeptanes, a log<i>D</i> Lowering TwistSébastien L Degorce, Michael S Bodnarchuk, James S Scott
Organic & Biomolecular Chemistry|December 12, 2017
Pd-Catalyzed C-H aziridination of 3,3,5,5-tetrasubstituted piperazin-2-onesThomas A Alanine, Stephen Stokes, Craig A Roberts, et al.
Pageof 7